Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor.

Antzeko izenburuak

• ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.
  nork: Kempf, D J, et al.
  Argitaratua: (1995)
• Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.
  nork: Ho, D D, et al.
  Argitaratua: (1994)
• In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor
  nork: Carrillo, Alejandro, et al.
  Argitaratua: (1998)
• Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.
  nork: Kaplan, A H, et al.
  Argitaratua: (1994)
• ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
  nork: Sham, Hing L., et al.
  Argitaratua: (1998)